HANLEY CONOR sold 47.6% of their position (5.69K shares) of KESTRA MEDICAL TECHNOLOGIES, LTD. on the open market
Open‑market sale worth $143.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2026ACC: 0001193125-26-388302
Director
Since Jun 2025
+1.52K
Net shares
Net buyer
$143.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
7.22K acquired · 5.69K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−5.69K
Price / share
$25.25
Trade value
$143.78K
% of position
47.6%
9/8/2026
11.97K→6.27K
Common Shares
Direct
Shares
+7.22K
Price / share
—
Trade value
—
% of position
115.1%
9/9/2026
6.27K→13.49K
Total
Net shares
+1.52K
Net value
-$143.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/8/2026 | S · Sale | −5.69K | $25.25 | $143.78K | 47.6% | 11.97K | 6.27K |
| Common Shares Direct | 9/9/2026 | A · Award | +7.22K | — | — | 115.1% | 6.27K | 13.49K |
| Total | +1.52K | -$143.78K | ||||||
Derivative Transactions0
No derivative transactions reported